Journal of Literature Pharmacy Sciences

Cilt Yaşlanması ve Matriks Metalloproteinaz Enzimlerinin Yaşlanma Üzerine Etkileri
Skin Aging and Effects of Matrix Metalloproteinase Enzymes on Aging
Mine UZUNa, L. Ömür DEMİREZERa
aFarmakognozi ABD, Hacettepe Üniversitesi Eczacılık Fakültesi, Ankara, TÜRKİYE
J Lit Pharm Sci. 2019;8(3):206-13
doi: 10.5336/pharmsci.2019-70792
Article Language: TR
Full Text
ÖZET
 Cilt yaşlanması hem kadın hem de erkekler için modern zamanların önemli sorunları arasında yer almaktadır. Yaşlanma yapısal ve moleküler bozulma ile beraber, derinin fonksiyon ve görüntüsünü etkileyen yavaş ve progresif seyreden karmaşık bir süreçtir. Bu süreç çeşitli iç ve dış etkenler ile şekillenmektedir. Temel olarak cilt yaşlanması; zamana bağlı olarak gelişen kronolojik yaşlanma (intrensek yaşlanma) ve başta güneşin zararlı ışınlarına maruziyet olmak üzere; sigara ve aşırı alkol kullanımı, yetersiz beslenme gibi olumsuz çevresel faktörlere bağlı olarak gelişen ekstrensek yaşlanma olmak üzere iki farklı şekilde gerçekleşmektedir. Deride görülen değişikliklerin %90'ından fazlası kronik güneş hasarının yol açtığı çevresel etkilere bağlıdır. Bu nedenle ekstrensek yaşlanma, aynı zamanda fotoyaşlanma olarak anılmaktadır. Yaşlanmanın önemli nedenlerinden olan matriks metalloproteinaz (MMP)lar ise ekstraselüler matriksteki kollajen ve diğer proteinlerin parçalanmasından sorumlu ana enzim grubudur. Kollajen, bağ dokusunun temel yapısal bileşenidir ve bozulması yaşlı görünmenin temel nedenlerindendir. MMP ailesi kolajenazlar, jelatinazlar, stromelisinler, matrilisinler, membran tipi MMP'ler ve diğer sınıflandırılmamış MMP'ler olmak üzere altı gruba ayrılmaktadır. MMP'ler yaşlanma ile ilgili olmalarının yanı sıra, birçok kanser çeşidinin oluşması ve ilerlemesiyle de yakından ilişkilidir. Bu çalışmada, cilt yaşlanmasına neden olan etmenler, organizmada meydana gelen birçok hastalıkla ilişkili önemli bir enzim ailesi olan MMP enzimleri ve yaşlanma ile olan ilişkileri araştırılmıştır.

Anahtar Kelimeler: Matriks metalloproteinazlar; deri yaşlanması; kollajenazlar
ABSTRACT
 Skin aging is one of the major problems of modern times for both men and women. Aging is a complicated and slow progressive process that affects the function and appearance of the skin with structural and molecular deterioration. This process is shaped by various internal and external factors. Skin aging as a basis takes place in two different ways: time-dependent chronological aging (intrinsic aging) and extrinsic aging due to negative environmental factors such as smoking and excessive alcohol use, and malnutrition. More than 90% of the skin changes are due to the environmental effects caused by chronic sun damage. Therefore, extrinsic aging is also referred to as photoaging. Matrix metalloproteinases (MMPs), a major cause of aging, are the main enzyme group responsible for the breakdown of collagen and other proteins in the extracellular matrix. Collagen is the main structural component of connective tissue, and its degradation is one of the main causes of aging. The MMP family is divided into six groups: Collagenases, gelatinases, stromelysins, matrilysins, membrane-type MMPs and other unclassified MMPs. MMPs are closely related to aging and the development and progression of many types of cancer. In this study, the factors that cause skin aging, MMP enzymes which are an important family of enzymes related to many diseases in organism and their relationship with aging are investigated.

Keywords: Matrix metalloproteinases; skin aging; collagenases
REFERENCES:
  1. Rittie L, Fisher GJ. Natural and sun-induced aging of human skin. Cold Spring Harbor Perspect Med. 2015;5(1):a015370. [Crossref]  [PubMed]  [PMC] 
  2. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2002;138(11):1462-70. [Crossref]  [PubMed] 
  3. Gilchrest BA. Skin aging and photoaging: an overview. J Am Acad Dermatol. 1989;21(3 Pt 2):610-3. [Crossref] 
  4. Brooke RC, Newbold SA, Telfer NR, Griffiths CE. Discordance between facial wrinkling and the presence of basal cell carcinoma. Arch Dermatol. 2001;137(6):751-4.
  5. Durai PC, Thappa DM, Kumari R, Malathi M. Aging in elderly: chronological versus photoaging. Indian J Dermatol. 2012;57(5):343-52. [Crossref]  [PubMed]  [PMC] 
  6. Tagami H. Functional characteristics of the stratum corneum in photoaged skin in comparison with those found in intrinsic aging. Arch Dermatol Res. 2008;300 Suppl 1:S1-6. [Crossref]  [PubMed] 
  7. West MD. The cellular and molecular-biology of skin aging. Arch Dermatol. 1994;130(1):87-95. [Crossref]  [PubMed] 
  8. Ichihashi M. Mechanisms of aging and photoaging of skin. How wrinkles are formed. Fragrance J. 2004;32:24-30.
  9. Elias PM, Goerke J, Friend DS. Mammalian epidermal barrier layer lipids: composition and influence on structure. J Invest Dermatol. 1977;69(6):535-46. [Crossref]  [PubMed] 
  10. Bernstein EF, Chen YQ, Tamai K, Shepley KJ, Resnik KS, Zhang H, et al. Enhanced elastin and fibrillin gene expression in chronically photodamaged skin. J Invest Dermatol. 1994;103(2):182-6. [Crossref]  [PubMed] 
  11. Bolognia JL. Aging skin. Am J Med. 1995;98(1A):99S-103S. [Crossref] 
  12. Davinelli S, Bertoglio JC, Polimeni A, Scapagnini G. Cytoprotective polyphenols against chronological skin aging and cutaneous photodamage. Curr Pharm Des. 2018;24(2):99-105. [Crossref]  [PubMed] 
  13. Scharffetter-Kochanek K, Brenneisen P, Wenk J, Herrmann G, Ma W, Kuhr L, et al. Photoaging of the skin from phenotype to mechanisms. Exp Gerontol. 2000;35(3):307-16. [Crossref] 
  14. Jenkins G. Molecular mechanisms of skin ageing. Mech Ageing Dev. 2002;123(7):801-10. [Crossref] 
  15. Kollias N, Sayre RM, Zeise L, Chedekel MR. Photoprotection by melanin. J Photochem Photobiol B. 1991;9(2):135-60. [Crossref] 
  16. Inoue Y, Shibasaki M. Regional differences in age-related decrements of the cutaneous vascular and sweating responses to passive heating. Eur J Appl Physiol Occup Physiol. 1996;74(1-2):78-84. [Crossref]  [PubMed] 
  17. Inoue Y, Shibasaki M, Ueda H, Ishizashi H. Mechanisms underlying the age-related decrement in the human sweating response. Eur J Appl Physiol Occup Physiol. 1999;79(2): 121-6. [Crossref]  [PubMed] 
  18. Wallace DC, Brown MD, Melov S, Graham B, Lott M. Mitochondrial biology, degenerative diseases and aging. Biofactors. 1998;7(3): 187-90. [Crossref]  [PubMed] 
  19. Saretzki G, Sitte N, Merkel U, Wurm RE, von-Zglinicki T. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene. 1999;18(37):5148-58. [Crossref]  [PubMed] 
  20. Gosain A, DiPietro LA. Aging and wound healing. World J Surg. 2004;28(3):321-6. [Crossref]  [PubMed] 
  21. Kurban RS, Bhawan J. Histologic changes in skin associated with aging. J Dermatol Surg Oncol. 1990;16(10):908-14. [Crossref]  [PubMed] 
  22. Ma W, Wlaschek M, Tantcheva-Poor I, Schneider LA, Naderi L, Razi-Wolf Z, et al. Chronological ageing and photoageing of the fibroblasts and the dermal connective tissue. Clin Exp Dermatol. 2001;26(7):592-9. [Crossref]  [PubMed] 
  23. Peres PS, Terra VA, Guarnier FA, Cecchini R, Cecchini AL. Photoaging and chronological aging profile: understanding oxidation of the skin. J Photochem Photobiol B. 2011;103(2):93-7. [Crossref]  [PubMed] 
  24. Quan T, Qin Z, Xia W, Shao Y, Voorhees JJ, Fisher GJ. Matrix-degrading metalloproteinases in photoaging. J Invest Derm Symp Proc. 2009;14(1):20-4. [Crossref]  [PubMed]  [PMC] 
  25. Wen KC, Fan PC, Tsai SY, Shih IC, Chiang HM. Ixora parviflora Protects against UV-B-induced photoaging by inhibiting the expression of MMPs, MAP kinases, and COX-2 and by promoting Type I procollagen synthesis. Evid Based Complement Alternat Med. 2012;2012:417346. [Crossref]  [PubMed]  [PMC] 
  26. Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239-47. [Crossref]  [PubMed] 
  27. Briganti S, Flori E, Picardo M. Intensity of oxidant stimulus, inflammation and cell senescence: possible implication in photoaging process. J Invest Dermatol. 2015;135:82.
  28. Trautinger F. Mechanisms of photodamage of the skin and its functional consequences for skin ageing. Clin Exp Dermatol. 2001;26(7):573-7. [Crossref]  [PubMed] 
  29. Chung JH, Hanft VN, Kang S. Aging and photoaging. J Am Acad Dermatol. 2003;49(4): 690-7. [Crossref] 
  30. Chung JH. Photoaging in Asians. Photodermatol Photoimmunol Photomed. 2003;19(3): 109-21. [Crossref]  [PubMed] 
  31. Freitas-Rodriguez S, Folgueras AR, Lopez-Otin C. The role of matrix metalloproteinases in aging: tissue remodeling and beyond. Biochim Biophys Acta Mol Cell Res. 2017;1864(11 Pt A):2015-25. [Crossref]  [PubMed] 
  32. Nagase H, Murphy G. Metalloproteinases, matrix A2. In: Lennarz WJ, Lane MD, eds. Encyclopedia of Biological Chemistry. 2nd ed. Waltham: Academic Press; 2013. p.90-7. [Crossref] 
  33. Reel B. [Matrix metalloproteinases and atherosclerosis: review]. Turkiye Klinikleri J Med Sci. 2006;26(5):527-37.
  34. Wojtowicz-Praga SM, Dickson RB, Hawkins MJ. Matrix metalloproteinase inhibitors. Invest New Drug. 1997;15(1):61-75. [Crossref]  [PubMed] 
  35. Jablonska-Trypuc A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(Suppl 1):177-83. [Crossref]  [PubMed] 
  36. Oncel M. [Matrix metalloproteinases and cancer]. Eur J Basic Med Sci. 2012;2(3):91-100.
  37. Kahari VM, Saarialho-Kere U. Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med. 1999;31(1):34-45. [Crossref]  [PubMed] 
  38. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004;48(5-6):411-24. [Crossref]  [PubMed] 
  39. Okada A, Seiki M. Matrix metalloproteinases in cancer invasion and metastasis. Igaku no Ayumi. 1997;182:114-8.
  40. Foda HD, Zucker S. Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discovery Today. 2001;6(9):478-82. [Crossref] 
  41. Miyagi Y, Yanoma S. Matrix metalloproteinases (MMPs) in tumor angiogenesis. Nippon Kessen Shiketsu Gakkaishi. 2001;12: 311-3. [Crossref] 
  42. Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, et al. Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer. 2008;8:77. [Crossref]  [PubMed]  [PMC] 
  43. Sauter W, Rosenberger A, Beckmann L, Kropp S, Mittelstrass K, Timofeeva M, et al. Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1127-35. [Crossref]  [PubMed] 
  44. Gijbels K, Masure S, Carton H, Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol. 1992;41(1):29-34. [Crossref] 
  45. Firestein GS. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis. Curr Opin Rheumatol. 1992;4(3):348-54. [Crossref]  [PubMed] 
  46. Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drug. 1997;15(3):175-85. [Crossref]  [PubMed] 
  47. Brown PD. Clinical studies with matrix metalloproteinase inhibitors. Apmis. 1999;107(1): 174-80. [Crossref]  [PubMed] 
  48. Bonnema DD, Webb CS, Pennington WR, Stroud RE, Leonardi AE, Clark LL, et al. Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs). J Card Fail. 2007;13(7):530-40. [Crossref]  [PubMed]  [PMC] 
  49. Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res. 2003;59(4):812-23. [Crossref] 
  50. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-39. [Crossref]  [PubMed] 
  51. Eisen AZ, Jeffrey JJ, Gross J. Human skin collagenase. Isolation and mechanism of attack on the collagen molecule. Biochim Biophys Acta. 1968;151(3):637-45. [Crossref] 
  52. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69(3):562-73. [Crossref]  [PubMed] 
  53. Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO. The extracellular matrix: tools and insights for the "omics" era. Matrix Biol. 2016;49:10-24. [Crossref]  [PubMed]  [PMC] 
  54. Wlaschek M, Briviba K, Stricklin GP, Sies H, Scharffetter-Kochanek K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol. 1995;104(2):194-8. [Crossref]  [PubMed] 
  55. Taddese S, Weiss AS, Neubert RH, Schmelzer CE. Mapping of macrophage elastase cleavage sites in insoluble human skin elastin. Matrix Biol. 2008;27(5):420-8. [Crossref]  [PubMed] 
  56. Taddese S, Weiss AS, Jahreis G, Neubert RH, Schmelzer CE. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. Matrix Biol. 2009;28(2):84-91. [Crossref]  [PubMed] 
  57. Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med. 2012;33(2):119-208. [Crossref]  [PubMed] 
  58. Liu Y, Lai J, Dong Y, He C. Research progress of MMP-1 and skin aging. Zhongguo Laonianxue Zazhi. 2010;30:3037-9.
  59. Masaki H. Skin aging mechanisms and materials. Nippon Koshohin Gakkaishi. 2013;37:11-6.
  60. Nema NK, Maity N, Sarkar BK, Mukherjee PK. Matrix metalloproteinase, hyaluronidase and elastase inhibitory potential of standardized extract of Centella asiatica. Pharm Biol. 2013;51(9):1182-7. [Crossref]  [PubMed] 
  61. Pittayapruek P, Meephansan J, Prapapan O, Komine M, Ohtsuki M. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci. 2016;17(6). [Crossref]  [PubMed]  [PMC] 
  62. Herrmann G, Wlaschek M, Lange TS, Prenzel K, Goerz G, Scharffetter-Kochanek K. UV-A irradiation stimulates the synthesis of various matrix-metalloproteinases (MMPs) in cultured human fibroblasts. Exp Dermatol. 1993;2(2): 92-7. [Crossref]  [PubMed] 
  63. Son WC, Yun JW, Kim BH. Adipose-derived mesenchymal stem cells reduce MMP-1 expression in UV-irradiated human dermal fibroblasts: therapeutic potential in skin wrinkling. Biosci Biotechnol Biochem. 2015;79(6):919-25. [Crossref]  [PubMed] 
  64. Onoue S, Kobayashi T, Takemoto Y, Sasaki I, Shinkai H. Induction of matrix metalloproteinase-9 secretion from human keratinocytes in culture by ultraviolet B irradiation. J Dermatol Sci. 2003;33(2):105-11. [Crossref]  [PubMed] 
  65. Kim HS, Song JH, Youn UJ, Hyun JW, Jeong WS, Lee MY, et al. Inhibition of UV-B-induced wrinkle formation and MMP-9 expression by mangiferin isolated from Anemarrhena asphodeloides. Eur J Pharmacol. 2012;689(1-3):38-44. [Crossref]  [PubMed] 
  66. Fortino V, Maioli E, Torricelli C, Davis P, Valacchi G. Cutaneous MMPs are differently modulated by environmental stressors in old and young mice. Toxicol Lett. 2007;173(2):73-9. [Crossref]  [PubMed] 
  67. Amano S. Characterization and mechanisms of photoageing-related changes in skin. Damages of basement membrane and dermal structures. Exp Dermatol. 2016;25 Suppl 3:14-9. [Crossref]  [PubMed] 
  68. Aimes RT, Quigley JP. Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments. J Biol Chem. 1995;270(11):5872-6. [Crossref]  [PubMed] 
  69. Chen Z, Seo JY, Kim YK, Lee SR, Kim KH, Cho KH, et al. Heat modulation of tropoelastin, fibrillin-1, and matrix metalloproteinase-12 in human skin in vivo. J Invest Dermatol. 2005;124(1):70-8. [Crossref]  [PubMed] 
  70. Shi LQ, Ruan CL. Expression and significance of MMP-7, c-Jun and c-Fos in rats skin photoaging. Asian Pac J Trop Med. 2013;6(10):768-70. [Crossref] 
  71. Kaar JL, Li Y, Blair HC, Asche G, Koepsel RR, Huard J, et al. Matrix metalloproteinase-1 treatment of muscle fibrosis. Acta Biomater. 2008;4(5):1411-20. [Crossref]  [PubMed] 
  72. Radbill BD, Gupta R, Ramirez MC, DiFeo A, Martignetti JA, Alvarez CE, et al. Loss of matrix metalloproteinase-2 amplifies murine toxin-induced liver fibrosis by upregulating collagen I expression. Dig Dis Sci. 2011;56(2):406-16. [Crossref]  [PubMed]  [PMC] 
  73. Balbin M, Fueyo A, Knauper V, Pendas AM, Lopez JM, Jimenez MG, et al. Collagenase 2 (MMP-8) expression in murine tissue-remodeling processes. Analysis of its potential role in postpartum involution of the uterus. J Biol Chem. 1998;273(37):23959-68. [Crossref]  [PubMed] 
  74. Ashworth JL, Murphy G, Rock MJ, Sherratt MJ, Shapiro SD, Shuttleworth CA, et al. Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling. Biochem J. 1999;340(Pt 1):171-81. [Crossref]  [PubMed]  [PMC] 
  75. Varani J, Spearman D, Perone P, Fligiel SE, Datta SC, Wang ZQ, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol. 2001;158(3):931-42. [Crossref] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com